BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2953367)

  • 1. Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin's disease.
    Nyman R; Rehn S; Glimelius B; Hagberg H; Hemmingsson A; Jung B
    Acta Radiol; 1987; 28(2):145-51. PubMed ID: 2953367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyst of lower mediastinum in a 14-year-old boy with tumor of mediastinum in the course of Hodgkin's disease].
    Gadomski A; Wagiel K
    Wiad Lek; 1998; 51 Suppl 4():331-3. PubMed ID: 10731994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
    Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
    Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
    Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
    Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rare differential diagnosis of a mediastinal space-occupying lesion].
    Bohle W; Rüther U; Jipp P
    Dtsch Med Wochenschr; 1999 Mar; 124(9):245-7. PubMed ID: 10102009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign mass lesions after therapy for Hodgkin's disease.
    Durkin W; Durant J
    Arch Intern Med; 1979 Mar; 139(3):333-6. PubMed ID: 426577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive skeletal invasion in Hodgkin's disease observed by MRI].
    Suzuki K; Tsuboi I; Inoue M; Sakuma A; Takizawa T; Koyama S; Sawada U; Kitami Y
    Rinsho Ketsueki; 1994 Feb; 35(2):142-7. PubMed ID: 8139111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
    Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)].
    Teillet E; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Asselain B; Dana M; Bernard J
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1369-74. PubMed ID: 477568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
    Tres A; Fuertes MA; Callén L; Poderós C; Rodrigo G; Peleato A; Polo J; Gutiérrez M
    Rev Esp Oncol; 1984; 31(3):477-82. PubMed ID: 6546176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presumed intraocular Hodgkin's disease.
    Bishop JE; Salmonsen PC
    Ann Ophthalmol; 1985 Sep; 17(9):589-92. PubMed ID: 4062168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal Hodgkin's disease.
    Vaeth JM; Moskowitz SA; Green JP
    AJR Am J Roentgenol; 1976 Jan; 126(1):123-6. PubMed ID: 175670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR evaluation of the mediastinal lymph nodes.
    Chakraborti KL; Jena A
    Indian J Chest Dis Allied Sci; 1997; 39(1):19-25. PubMed ID: 9100407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.